Source
20 developments in the corpus
Latest
Everything in the corpus, newest first.
OCT 20, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Diosmetin (Dio) is a natural flavonoid with broad-spectrum anticancer activity against various malignancies through mechanisms involving cell cycle arrest, apoptosis induc
OCT 19, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Prostate cancer remains one of the leading causes of cancer-related death among men worldwide. Photodynamic therapy (PDT) has emerged as a promising strategy to enhance co
OCT 14, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Tumor microenvironment is closely involved in breast cancer progression and metastatic spread. Therefore, it is essential to develop a combination therapy to suppress tumo
OCT 13, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract The antagonism of cannabinoid 1 receptor (CB1R) signaling has demonstrated clinical efficacy in treating obesity, improving insulin resistance, enhancing cardiovascular he
OCT 13, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Skin cancer therapy still presents limitations regarding efficacy and invasiveness, which highlights the need for alternative therapeutic approaches. Quercetin has emerged
OCT 8, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Osteosarcoma is the most common type of bone cancer and is known for its high likelihood of metastasis. Rosmarinic acid (RA) and nordihydroguaiaretic acid (NDGA) are plant
OCT 6, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Protein–protein interactions (PPIs) are central to physiological and pathophysiological processes. Identifying PPI modulators is the first step toward the development of n
OCT 2, 2026 · JOURNAL ARTICLE
Acs Omega
Abstract Berberine, a natural isoquinoline alkaloid derived fromCoptidis rhizoma has long been used in traditional medicine and has recently attracted attention for its potential r